Business Case: Strategic Remediation and Capacity Expansion for IV Drug Products

Executive Summary

This project focused on expanding production capacity at a sterile drug manufacturing facility in the USA to meet growing market demands in North America. As Senior Project Manager, I proactively led the remediation of the project when scope creep arose due to regulatory hurdles with pre-inspection approvals. I coordinated cross-functional teams, facilitated strategic decision-making, and implemented Lean Six Sigma principles alongside a Hybrid project management approach. Through my direction, the project objectives were successfully realigned to ensured compliance, and delivered measurable ROI within a revised framework.

Framework Approach

Primary Methodology:

Lean Six Sigma: Streamlined processes and minimized waste.

Hybrid Project Management: Agile adaptability for real-time issue resolution and Waterfall structure for compliance-critical phases.

Initial Scope and Challenges:

• Goal: Expansion to increase the production of total 20 sterile drug products while maintaining stringent sterility and quality standards.
• Installation, commissioning, qualification, and validation of new equipment, with minimal operational disruption.
• Secure regulatory approval from FDA (USA) and HC (Canada) to meet time-to-market goals.
• Challenges Identified:
  • Regulatory delays affecting timelines for FDA (USA) and HC (Canada) approvals.
  • Scope creep due to evolving pre-inspection requirements.
  • High-risk complexity (potential contamination, supply chain impact).

 Key Parameters:     

Budget: Adjusted to $300M (original: $350M, contingency: $10M).

Timeframe: Extended to 30 months (original: 24 months).

Risk Mitigation: Proactively addressed risks with Failure Mode and Effects Analysis (FMEA).

Project Execution

Remediation and Realignment:

• Conducted a gap analysis and redefined critical priorities to focus on 10 essential sterile drug products.
• Collaborated with cross-functional stakeholders to navigate regulatory pathways and streamline approval processes.
• Built a six-month inventory buffer to mitigate supply disruption risks.

Phases and Key Achievements:

1. Equipment Commissioning and Qualification:

   • Completed IQ, OQ, and PQ for advanced dehydrogenation tunnels and vial filling systems within controlled timelines.
   • Implemented process simulations to ensure readiness for full-scale production.

2. Regulatory Approvals:

   • Secured FDA and HC approvals ahead of revised timelines (6 months and 10 months, respectively).

3. Process Validation and Market Launch:

• Completed validation using exhibit batches, enabling faster market entry.
• Reduced time-to-market for USA and Canada to 3 months (target: 6 months) 

Results and Benefits

Operational Efficiency:

• Increased production capacity for 10 critical sterile drug products.
• Achieved a 25% reduction in per-unit production costs by deprioritizing non-critical products.
• Enhanced production throughput by 30% through optimized workflows.

Financial Impact:

• Delivered the project within the revised budget of $300M.
• Enabled $300M incremental revenue over five years.

Regulatory and Market Success:

• Met all FDA and HC compliance requirements, establishing the facility as a benchmark for future expansions.
• Prevented market supply disruptions through proactive planning and contingency strategies.

Operational Continuity

• Strategically scheduled downtime to align with low-demand periods, ensuring minimum or no disruption to critical markets.
• Built a six-month inventory buffer to safeguard against unforeseen delays.

Tools and Techniques for Success

• Lean Six Sigma: Applied Value Stream Mapping and Risk Matrix to eliminate inefficiencies.
• Hybrid Framework: Integrated Waterfall methodology for structured equipment qualification, validation, and submission timelines with Agile stand-ups for real-time issue resolution and adaptability.
• PM Tools: Gantt Charts, Dashboards, and Kanban Boards for progress tracking and stakeholder engagement.
• Smartsheet: Deployed to manage timelines, resource allocation, and task assignments with real-time updates for all stakeholders.
•  Kanban Board: Employed to visualize task progression, manage workload distribution, and ensure accountability across cross-functional teams. 
• Gantt Charts: Used for detailed scheduling, tracking milestones, and dependencies.
• Dashboards: Comprehensive project dashboards provided real-time visibility into progress, KPIs, and budget utilization.
• Risk Management Framework: Conducted Failure Mode and Effects Analysis (FMEA) to preemptively address potential risks, including contamination, production disruptions, and supply chain delays.

·       Feedback Loops for Continuous Learning: Established project dashboards to collect and address team feedback post-training sessions, enabling continuous improvement and reinforcing operational alignment with new SOPs.

Communication Tools: Established collaboration platforms for seamless coordination between engineering, QA, regulatory affairs, and supply chain teams, ensuring prompt resolution of issues.

Conclusion

This project highlights the transformative impact of strategic remediation, leveraging blended Lean Six Sigma with the Hybrid project management approach, to realign scope, overcome regulatory hurdles, and achieve measurable success. When scope creep and pre-inspection regulatory challenges threatened timelines and budgets, I led a targeted remediation plan that refocused priorities, streamlined processes, and optimized resources.

By deploying the right tools and techniques—such as Gantt Charts for revised scheduling, Kanban Boards for task visibility, and FMEA for proactive risk management—I ensured the project returned to trajectory, met redefined goals, and remained compliant with regulatory standards.

Proactively addressing risks and reallocating resources not only preserved operational continuity but also enhanced project efficiency. By integrating adaptive learning and fostering a culture of collaboration, the team swiftly adopted optimized processes, securing uninterrupted market supply.

This project delivered significant value across the triple bottom line:

• People: Empowered cross-functional teams through knowledge transfer and effective collaboration during a high-stress remediation phase.
• Planet: Incorporated sustainable practices in equipment requalification and process redesign, minimizing environmental impact.
• Profit: Delivered ROI by refocusing on critical products, ensuring increased production capacity while maintaining budget discipline under the adjusted $300M target. and securing regulatory approvals within ambitious timelines.

The success of this initiative positions it as a benchmark for managing high-complexity projects in regulated industries, demonstrating how strategic alignment, robust risk management, and a focus on sustainable growth can drive long-term benefits. My leadership and application of advanced project management principles ensured the realization of both immediate goals and a framework for future scalability.

Ready to achieve similar results in your organization?
Let’s connect to explore how my expertise in regulatory compliance, project management, and sustainable solutions can help you overcome challenges and achieve your strategic objectives. 

Reach out today, and let’s drive success together!